Results 151 to 160 of about 938,592 (268)
Current advances in 2025: A critical review of selected topics by the Association for the Advancement of Blood and Biotherapies (AABB) Clinical Transfusion Medicine Committee
Transfusion, EarlyView.Nabiha H. Saifee, Jennifer Andrews, Mary Berg, Stella T. Chou, Mischa Covington, Elizabeth P. Crowe, Ruchika Goel, Juliana A. Guarente, Tina Ipe, Jeremy W. Jacobs, Jessica Jacobson, Cyril Jacquot, Jenna Khan, Thane A. Kubik, Theodros Mamo, Michael F. Murphy, Kerry O'Brien, Monica B. Pagano, Anil K. Panigrahi, Jacqueline N. Poston, Scott E. Potter, Simon J. Stanworth, Moritz Stolla, Alyssa Ziman, Ryan A. Metcalf +24 morewiley +1 more sourceReal‐World Effectiveness and Safety of Sofosbuvir‐Based Therapy in Chinese Children and Adolescents With Chronic HCV Infection: A Retrospective Multicentre Study
Journal of Viral Hepatitis, Volume 33, Issue 12, December 2026.ABSTRACT
Few direct‐acting antiviral regimens are approved in China for children and adolescents with chronic hepatitis C virus (HCV) infection and data are limited on their efficacy and safety in this population. This retrospective, multi‐centre study aimed to assess the real‐world effectiveness and safety of ledipasvir/sofosbuvir (LDV/SOF) and ...Li Liu, Mei Li, Shishu Zhu, Yi Dong, Hongmei Zu, Ping Yu, Ruiling Liu, Yan Chen, Joshua Lin, Carl Gustafson, Heribert Ramroth, Lin Liu, Yanwen Luo +12 morewiley +1 more sourceLonger-Term Clinical Outcomes From the THINKER and EXPANDER Trials of Transplantation of HCV-RNA+ Donor Kidneys Into Hepatitis C Virus-Negative Recipients. [PDF]
Kidney Int Rep, 2023 Potluri V, Naqvi F, Goldberg DS, Shah M, Loupy A, Abt P, Blumberg E, Trofe-Clark J, Bloom R, Sawinski D, Chattergoon M, Segev DL, Bair-Marcantoni N, Durand CM, Reddy R, Levine M, Brown N, Mapchan S, Aubert O, Desai N, Reese PP. +20 moreeuropepmc +1 more sourceReductions in Advanced Chronic Liver Disease Among People Who Inject Drugs: The ETHOS Engage Study
Liver International, Volume 46, Issue 12, December 2026.ABSTRACT Background and Aims
Liver disease is a significant risk for people who inject drugs due to the high burden of hepatitis C virus (HCV). There is limited data on the impact of the direct‐acting antiviral (DAA) therapy era on liver disease among people who inject drugs.Anna Conway, Heather Valerio, Jessie Payne, David Silk, Alison D. Marshall, Marianne Martinello, Shane Tillakeratne, Putu Novi Arfirsta Dharmayani, Andrew Milat, Janaki Amin, Phillip Read, Louisa Degenhardt, Annabelle Stevens, Jeremy Hayllar, Michael Christmass, Victoria Cock, Jessica Doumany, Jason Grebely, Gregory J. Dore, on behalf of the ETHOS Engage Study Group, Amanda Erratt, Kyle Leadbeatter, Carla Treloar, Adrian Dunlop, Carolyn Murray, Mary Ellen Harrod, Mel Rhagnath, Clarke Scott, Vicky Cock, Jess Doumany, Dominic Mounsey, Maria Martinez, Amanda Erratt, Nadine Ezard, Craig Rodgers, David Reid, Carla Gorton, Jeremy Hayllar, Thao Lam, Adrian Dunlop, Prasun Datta, Alex Wade, Sally Spruce, Vicki Cock, Sarah Michelmore, Mark Cornwell, Krista Zohrab, Kate Salisbury, Patricia Collie, Craig Connelly, Angela Cooper, Mark Montebello, Chris Gough, Robert Cherry, Julie Dyer, Shikha Agrawal, Elke Press, Alice Wang, Teodora Zanesheva‐Karamanlieva, Eleanor Kessler, Nadine Horasak, Rhondda Lewis, Astrid Carthew, Daniel Morris, Kathy Donohue, Faith Bassett, Kathy Griffiths, Jason Dalla Lana, Sue Shin, Kylie Page, Julie Luff, Rebecca Hyland, Jane Booty, Todd McKillop, Connie Graf, Adele Hampson, Siyu Qian, Danielle Brown, Amber Lautier, Cate Curran, Peta McAlister, Peter Warburton, Rachel Pollard, Daniel Pekin‐Stores, Jessica Rees, Danielle Gaudiosi, Tammy Raikko, Martina Camitz, Corrie Brandsma‐McGrath, Emma Harkins, Nicole Stuart, Coby‐Lea Chalker, Carly Harvey, Edwin Christopher, David Khalil, Kerry McMorrow, Melissa Wellman, Carina Burns, Ravina Raidu, Kylie Stolzenhein, Wanda Brabender, Kelly Somes, Gary Keogh, Isabella Conwell, Nargis Abram, Rick Turner, Stuart Larter, Fiona Goodberg, Jennifer Luksza, Meryem Jefferies, Michelle Hall, Susan Hazelwood, Charlotte Ismay, Antoni Pazeski, Bettina Sweetman, Michelle Gallagher, Cecily Willis, Amanda Brown, Belinda McClurg, Cherie Mincham, Kali Barlow, Anita Hoskins, Laura Johnson, Courtney Priestley, Amie Johns, Shane Moore, Kerrie‐Ann Lahrs, Julie Markham, Jacky Talmet, Sandy Dunn, Amanda Mitchell, Lauren Bright, May Lee, Alcohol Services, Bronwyn Gordon, Blair Brewerton, Michael Wallace, Andrew McKinnon, Fionnuala Smyth, Lisa Snell, Elizabeth Laing, Martin Clark, Justin Dorigo, Louise Carman, Toni Hamilton, Ching Tan, Deidre O'Shea, Brent Fergusson, Bonny Puszka, Gai Duncan, Fiona Baker, Jayde Walsh, Leeann Walsh, Hannah Cook, Natasha Nikolic, Louise Hughes, Julia Bitmead, Dean Wang, Kareen Tait, Sav Gollapally, Cáitleen Moloney, Sarah Ahmed +161 morewiley +1 more sourceOptimal Frequency of Hepatitis C Virus (HCV) RNA Testing for Detection of Acute HCV Infection Among At-risk People With Human Immunodeficiency Virus: A Multicenter Study. [PDF]
Open Forum Infect Dis, 2023 Sun HY, Liou BH, Chen TC, Yang CJ, Huang SH, Lu PL, Huang CH, Tsai MS, Cheng SH, Lee NY, Ko WC, Chen YH, Liu WD, Lin SY, Lin SP, Chen PL, Syue LS, Huang YS, Chuang YC, Chen CB, Chang YT, Lee YT, Hsieh SM, Su LH, Cheng CY, Hung CC. +25 moreeuropepmc +1 more sourceEBV‐Driven ODC1 Upregulation Enhances Polyamine Anabolism to Promote Viral Replication and Cisplatin Resistance in Nasopharyngeal Carcinoma
Advanced Science, Volume 13, Issue 61, 3 November 2026.EBV‑BZLF1 initiates ODC1‑driven polyamine anabolism that correlates with poor clinical prognosis in nasopharyngeal carcinoma. The ODC1–spermidine axis promotes viral replication, cell proliferation and innate immune evasion. Pharmacological inhibition of ODC1 rescues cisplatin sensitivity, establishing ODC1 as a viable therapeutic target for EBV ...Yueshuo Li, Xudong Hu, Chenxing Yang, Na Liu, Lin Wang, Xi Cai, Min Tang, Ya Cao, Li Shang, Feng Shi +9 morewiley +1 more source